Back to Results
First PageMeta Content
Kidney diseases / Organ failure / Nephrology / Acute kidney injury / Nephrotoxicity / Albuminuria / Biomarker / Renal function / V / Medicine / Biology / LCN2


NGAL STRONG EVIDENCE SUPPORTS NGAL AS A KIDNEY BIOMARKER THE NGAL BRIDGE
Add to Reading List

Document Date: 2015-03-27 05:48:48

Open Document

File Size: 1,53 MB

Share Result on Facebook

City

Specificity / Kaohsiung / Power / /

Company

Nephrotoxicity Working Group / BioPorto Diagnostics / BW 008 Diagnostics BioPorto Diagnostics A/S / /

/

IndustryTerm

treatment of diverse renal diseases / /

MedicalCondition

kidney injury / albuminuria / cisplatin-induced acute kidney injury / diseases / acute kidney injury / renal injury / /

Organization

FDA / /

Person

BUN GGT NGAL / AKI A NGAL / ELISA HYB / ELISA ABS / /

/

Position

gentamicin-induced nephrotoxicity model / WB / /

Product

gentamicin / cisplatin / /

ProvinceOrState

Nebraska / /

Technology

Antibodies / /

URL

http /

SocialTag